Anti-PKN3 (phospho T718) + PRK1 (phospho T774) + PKN2 (phospho T816) antibody [EPR5671]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal PKN3 phospho T718 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 2 publications.
View Alternative Names
PKNBETA, PKN3, Serine/threonine-protein kinase N3, Protein kinase PKN-beta, Protein-kinase C-related kinase 3, PAK1, PKN, PRK1, PRKCL1, PKN1, Serine/threonine-protein kinase N1, Protease-activated kinase 1, Protein kinase C-like 1, Protein kinase C-like PKN, Protein kinase PKN-alpha, Protein-kinase C-related kinase 1, Serine-threonine protein kinase N, PAK-1, PRK2, PRKCL2, PKN2, Serine/threonine-protein kinase N2, PKN gamma, Protein kinase C-like 2, Protein-kinase C-related kinase 2
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-PKN3 (phospho T718) + PRK1 (phospho T774) + PKN2 (phospho T816) antibody [EPR5671] (AB124709)
ab124709, at 1/10, staining PKN1 (phospho T774) + PKN2 (phospho T816) + PKN3 (phospho T718) in permeabilized Hek 293 cells by intracellular flow cytometry. Green : untreated cells Red : Okadaic Acid + Calyculin A-treated cells Blue : untreated cells preincubated with the immunizing phosphopeptides Orange : Okadaic Acid + Calyculin A-treated cells preincubated with the immunizing phosphopeptides.
- WB
Unknown
Western blot - Anti-PKN3 (phospho T718) + PRK1 (phospho T774) + PKN2 (phospho T816) antibody [EPR5671] (AB124709)
Bottom blot was probed with an anti-PNK2 antibody.
All lanes:
Western blot - Anti-PKN3 (phospho T718) + PRK1 (phospho T774) + PKN2 (phospho T816) antibody [EPR5671] (ab124709) at 1/1000 dilution
Lane 1:
HeLa cell lysate untreated at 10 µg
Lane 2:
HeLa cell lysate treated with Okadaic acid and Calyculin A. at 10 µg
Predicted band size: 104 kDa,112 kDa
false
Related conjugates and formulations (1)
-
Anti-PKN3 (pT718) + PRK1 (pT774) + PKN2 (pT816) antibody [EPR5671] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of cellular and molecular medicine 26:5713-5727 PubMed36308410
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 10: PubMed28851822
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com